{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:34:05Z","timestamp":1793133245117,"version":"4.5.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI18\/00576"],"award-info":[{"award-number":["PI18\/00576"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD21\/0009\/0008"],"award-info":[{"award-number":["RD21\/0009\/0008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.phrs.2025.107657","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:16:29Z","timestamp":1739906189000},"page":"107657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders"],"prefix":"10.1016","volume":"213","author":[{"given":"Mar\u00eda S.","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham B.","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"The structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107657_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-6980(00)00051-4","article-title":"Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol","volume":"61","author":"Hillard","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"11","key":"10.1016\/j.phrs.2025.107657_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"6604","key":"10.1016\/j.phrs.2025.107657_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107657_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","volume":"121","author":"Dinh","year":"2002","journal-title":"Chem. Phys. Lipids"},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0165-6147(00)01712-0","article-title":"Anandamide: some like it hot","volume":"22","author":"Di Marzo","year":"2001","journal-title":"Trends Pharm. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib9","first-page":"129","article-title":"Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections","volume":"112","author":"Herkenham","year":"1991","journal-title":"NIDA Res Monogr."},{"key":"10.1016\/j.phrs.2025.107657_bib10","article-title":"Endocannabinoid signaling in stress, nausea, and vomiting","author":"DeVuono","year":"2024","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/fcp.12821","article-title":"Protective effects of cannabis sativa on chemotherapy-induced nausea in a rat: involvement of CB1 receptors","volume":"37","author":"Elgohary","year":"2023","journal-title":"Fundam. Clin. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14728222.2024.2407824","article-title":"The endocannabinoid system as a therapeutic target in neuropathic pain: a review","volume":"28","author":"Quintero","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2003.tb03227.x","article-title":"Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2","volume":"996","author":"Jorda","year":"2003","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"5746","key":"10.1016\/j.phrs.2025.107657_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garcia-Gutierrez","year":"2010","journal-title":"Br. J. Pharm."},{"issue":"6441","key":"10.1016\/j.phrs.2025.107657_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur. J. Biochem"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11481-017-9744-7","article-title":"Regulation of cell surface cB(2) receptor during human B cell activation and differentiation","volume":"12","author":"Castaneda","year":"2017","journal-title":"J. Neuroimmune Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0167-4781(96)00047-4","article-title":"Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor","volume":"1307","author":"Shire","year":"1996","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(97)01336-8","article-title":"Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals","volume":"339","author":"Griffin","year":"1997","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S0952523800171093","article-title":"Expression of CB2 cannabinoid receptor mRNA in adult rat retina","volume":"17","author":"Lu","year":"2000","journal-title":"Vis. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/syn.20856","article-title":"Distribution of CB2 cannabinoid receptor in adult rat retina","volume":"65","author":"Lopez","year":"2011","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-4781(02)00341-X","article-title":"Cloning and molecular characterization of the rat CB2 cannabinoid receptor","volume":"1576","author":"Brown","year":"2002","journal-title":"Biochim Biophys. Acta"},{"issue":"15","key":"10.1016\/j.phrs.2025.107657_bib27","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1046\/j.1432-1033.2002.03078.x","article-title":"Presence and regulation of the endocannabinoid system in human dendritic cells","volume":"269","author":"Matias","year":"2002","journal-title":"Eur. J. Biochem"},{"issue":"35","key":"10.1016\/j.phrs.2025.107657_bib28","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107657_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0378-1119(03)00638-3","article-title":"Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates","volume":"312","author":"McPartland","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2025.107657_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.gene.2005.11.004","article-title":"Evolutionary origins of the endocannabinoid system","volume":"370","author":"McPartland","year":"2006","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2006.09.016","article-title":"Characterization of two duplicate zebrafish Cb2-like cannabinoid receptors","volume":"389","author":"Rodriguez-Martin","year":"2007","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes Brain Behav."},{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/syn.20569","article-title":"Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus","volume":"62","author":"Brusco","year":"2008","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"25","author":"Garcia-Gutierrez","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1476-5381.2011.01625.x","article-title":"Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors","volume":"165","author":"Garcia-Gutierrez","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib37","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/npp.2012.22","article-title":"Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB(2) receptors","volume":"37","author":"Aracil-Fernandez","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2025.107657_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1196\/annals.1432.037","article-title":"Ultrastructural localization of neuronal brain CB2 cannabinoid receptors","volume":"1139","author":"Brusco","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.phrs.2025.107657_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid system components: overview and tissue distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Adv. Exp. Med Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881110367732","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2025.107657_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroscience.2015.10.041","article-title":"Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus","volume":"311","author":"Li","year":"2015","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","article-title":"Alterations in gene and protein expression of cannabinoid CB(2) and GPR55 receptors in the dorsolateral prefrontal cortex of suicide victims","volume":"15","author":"Garcia-Gutierrez","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2025.107657_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2019.03.040","article-title":"Mechanisms of cannabinoid CB(2) receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area","volume":"42","author":"Ma","year":"2019","journal-title":"EBioMedicine"},{"issue":"19","key":"10.1016\/j.phrs.2025.107657_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195984","article-title":"Cannabinoid receptor 2 alters social memory and microglial activity in an age-dependent manner","volume":"26","author":"Komorowska-Muller","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib48","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib49","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.93.9.3984","article-title":"The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons","volume":"93","author":"Skaper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(00)00307-6","article-title":"In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors","volume":"109","author":"Sacerdote","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jcb.1103","article-title":"Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids","volume":"81","author":"Chang","year":"2001","journal-title":"J. Cell Biochem"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib52","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","article-title":"Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor","volume":"139","author":"Klegeris","year":"2003","journal-title":"Br. J. Pharm."},{"issue":"16","key":"10.1016\/j.phrs.2025.107657_bib53","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","article-title":"Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia","volume":"23","author":"Molina-Holgado","year":"2003","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0706215","article-title":"Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1\/2 kinase signaling","volume":"145","author":"Correa","year":"2005","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.20229","article-title":"Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures","volume":"52","author":"Ortega-Gutierrez","year":"2005","journal-title":"Glia"},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107657_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2006.08.001","article-title":"In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids","volume":"181","author":"Roche","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"3-4","key":"10.1016\/j.phrs.2025.107657_bib57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000110644","article-title":"Cannabinoid system and neuroinflammation: implications for multiple sclerosis","volume":"14","author":"Correa","year":"2007","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clim.2006.11.002","article-title":"CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents","volume":"122","author":"Lombard","year":"2007","journal-title":"Clin. Immunol."},{"issue":"1-3","key":"10.1016\/j.phrs.2025.107657_bib59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2006.05.025","article-title":"AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"542","author":"Kim","year":"2006","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1471-4159.2006.04346.x","article-title":"The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset","volume":"101","author":"Shoemaker","year":"2007","journal-title":"J. Neurochem."},{"issue":"23","key":"10.1016\/j.phrs.2025.107657_bib61","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2174\/138161208785740081","article-title":"The endocannabinoid system in amyotrophic lateral sclerosis","volume":"14","author":"Bilsland","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2025.107657_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-8069-5-25","article-title":"Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation","volume":"5","author":"Romero-Sandoval","year":"2009","journal-title":"Mol. Pain."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/STROKEAHA.111.631044","article-title":"Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage\/microglial activation concomitant to neuroprotection","volume":"43","author":"Zarruk","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2025.107657_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/824093","article-title":"Update on the role of cannabinoid receptors after ischemic stroke","volume":"2012","author":"Capettini","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.phrs.2025.107657_bib65","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2011.01673.x","article-title":"Cannabinoid CB(2) receptors modulate ERK-1\/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide","volume":"165","author":"Merighi","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib66","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107657_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Martin-Moreno","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062511","article-title":"Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis","volume":"8","author":"Malfitano","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.phrs.2025.107657_bib69","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/bph.12607","article-title":"Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice","volume":"171","author":"Zoppi","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107657_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2014.04.034","article-title":"Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats","volume":"342","author":"Fujii","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132487","article-title":"Time-dependent protection of CB2 receptor agonist in stroke","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107657_bib72","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease","volume":"64","author":"Gomez-Galvez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107657_bib73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fnins.2016.00321","article-title":"Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson's disease","volume":"10","author":"Javed","year":"2016","journal-title":"Front Neurosci."},{"key":"10.1016\/j.phrs.2025.107657_bib74","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2016.03.018","article-title":"CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury","volume":"279","author":"Lopez-Rodriguez","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107657_bib75","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbi.2017.10.021","article-title":"Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization","volume":"68","author":"Braun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107657_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112439","article-title":"Antidepressant-like effects of beta-caryophyllene on restraint plus stress-induced depression","volume":"380","author":"Hwang","year":"2020","journal-title":"Behav. Brain Res"},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib77","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1038\/s41401-021-00853-8","article-title":"CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK\/AKT-Nurr1 signal pathways","volume":"43","author":"Han","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2025.107657_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105769","article-title":"Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARgamma","volume":"177","author":"Rodrigues","year":"2024","journal-title":"Neurochem. Int"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib79","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3565(25)12097-1","article-title":"Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes","volume":"275","author":"Lee","year":"1995","journal-title":"J. Pharm. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib80","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur. J. Biochem"},{"issue":"2-3","key":"10.1016\/j.phrs.2025.107657_bib81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"Nunez","year":"2004","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1189\/jlb.0205111","article-title":"Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders","volume":"78","author":"Sipe","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib84","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1124\/mol.105.018325","article-title":"Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells","volume":"69","author":"Borner","year":"2006","journal-title":"Mol. Pharm."},{"issue":"14","key":"10.1016\/j.phrs.2025.107657_bib85","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.molimm.2006.01.005","article-title":"Cannabinoid receptor CB2 modulates the CXCL12\/CXCR4-mediated chemotaxis of T lymphocytes","volume":"43","author":"Ghosh","year":"2006","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib86","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.bjp.0707466","article-title":"CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies","volume":"153","author":"Arevalo-Martin","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib88","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jep.2007.10.023","article-title":"The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action","volume":"115","author":"Palu","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib89","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.24395","article-title":"The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis","volume":"60","author":"Akhmetshina","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib90","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11481-013-9485-1","article-title":"Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction","volume":"8","author":"Robinson","year":"2013","journal-title":"J. Neuroimmune Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib91","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/ket447","article-title":"Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis","volume":"53","author":"Gui","year":"2014","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2025.107657_bib92","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2050-6511-15-30","article-title":"Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion","volume":"15","author":"Feng","year":"2014","journal-title":"BMC Pharm. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib93","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1574889810666160421121726","article-title":"Immuno-modulatory properties of a quinolin-2-(1H)-on-3-carboxamide derivative: relevance in multiple sclerosis","volume":"10","author":"Malfitano","year":"2016","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.phrs.2025.107657_bib94","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2016.05.020","article-title":"Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1\/M2 polarization through the cAMP\/PKA pathway in an experimental GMH rat model","volume":"58","author":"Tao","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107657_bib95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2016.12.009","article-title":"Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis","volume":"303","author":"Annunziata","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107657_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biochi.2017.02.009","article-title":"Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15","volume":"135","author":"Malfitano","year":"2017","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040691","article-title":"(-)-beta-caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis","volume":"18","author":"Alberti","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107657_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109025","article-title":"A selective CB(2) agonist protects against the inflammatory response and joint destruction in collagen-induced arthritis mice","volume":"116","author":"Bai","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib99","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.120.000479","article-title":"Cannabidiol enhances intestinal cannabinoid receptor type 2 receptor expression and activation increasing regulatory T cells and reduces murine acute graft-versus-host disease without interfering with the graft-versus-leukemia response","volume":"377","author":"Berg","year":"2021","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.107657_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107832","article-title":"Cannabinoid-induced changes in the immune system: the role of microRNAs","volume":"98","author":"Bhatt","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12768","article-title":"Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis","volume":"48","author":"Tiberi","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107657_bib102","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301325R","article-title":"The endocannabinoid anandamide activates pro-resolving pathways in human primary macrophages by engaging both CB(2) and GPR18 receptors","volume":"38","author":"Leuti","year":"2024","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib103","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0166-2236(97)01065-5","article-title":"Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity","volume":"20","author":"Holscher","year":"1997","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib104","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PHM.0000000000000904","article-title":"Impaired cognitive performance in endothelial nitric oxide synthase knockout mice after ischemic stroke: a pilot study","volume":"97","author":"Li","year":"2018","journal-title":"Am. J. Phys. Med Rehabil."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00437-4","article-title":"Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide","volume":"401","author":"Ross","year":"2000","journal-title":"Eur. J. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2025.107657_bib106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jnr.10165","article-title":"Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures","volume":"67","author":"Molina-Holgado","year":"2002","journal-title":"J. Neurosci. Res"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/glia.20108","article-title":"Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes","volume":"49","author":"Sheng","year":"2005","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib108","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0703902","article-title":"Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide","volume":"132","author":"Lagneux","year":"2001","journal-title":"Br. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107657_bib109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-006-2346-y","article-title":"Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production","volume":"283","author":"Shmist","year":"2006","journal-title":"Mol. Cell Biochem"},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib110","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"ML. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib111","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garcia-Arencibia","year":"2007","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib112","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1194\/jlr.M001511","article-title":"The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages","volume":"51","author":"Hao","year":"2010","journal-title":"J. Lipid Res"},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib113","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta(9)-THCV in animal models of Parkinson's disease","volume":"163","author":"Garcia","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"14","key":"10.1016\/j.phrs.2025.107657_bib114","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","article-title":"Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway","volume":"29","author":"Viscomi","year":"2009","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00109-011-0846-z","article-title":"Distinct regulation of nNOS and iNOS by CB2 receptor in remote delayed neurodegeneration","volume":"90","author":"Oddi","year":"2012","journal-title":"J. Mol. Med."},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib116","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1476-5381.2012.01948.x","article-title":"2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells","volume":"166","author":"Merighi","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib117","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","article-title":"Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury","volume":"182","author":"Choi","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2025.107657_bib118","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2013.11.026","article-title":"Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease","volume":"73","author":"Gonzalez-Naranjo","year":"2014","journal-title":"Eur. J. Med Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib119","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12031-014-0243-5","article-title":"Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-kappaB activation in microglia","volume":"54","author":"Guo","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1567202613666160902102007","article-title":"Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia","volume":"13","author":"Jayant","year":"2016","journal-title":"Curr. Neurovasc Res"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020426","article-title":"Preventive effects of resveratrol on endocannabinoid system and synaptic protein modifications in rat cerebral cortex challenged by bilateral common carotid artery occlusion and reperfusion","volume":"19","author":"Carta","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107657_bib122","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2018.12.001","article-title":"Promising neuroprotective effects of beta-caryophyllene against LPS-induced oligodendrocyte toxicity: a mechanistic study","volume":"159","author":"Askari","year":"2019","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopha.2018.11.039","article-title":"Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: the role of CB2 and PPAR-gamma receptors","volume":"110","author":"Youssef","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib124","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2018.12.059","article-title":"The protective effects of beta-caryophyllene on LPS-induced primary microglia M(1)\/M(2) imbalance: a mechanistic evaluation","volume":"219","author":"Askari","year":"2019","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib126","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med"},{"key":"10.1016\/j.phrs.2025.107657_bib127","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharm. Ther."},{"issue":"23","key":"10.1016\/j.phrs.2025.107657_bib128","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB(2) receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib129","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications","volume":"12","author":"Fernandez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.mcn.2004.09.004","article-title":"Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase\/AKT signaling","volume":"28","author":"Molina-Holgado","year":"2005","journal-title":"Mol. Cell Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib133","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2011.01414.x","article-title":"Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K\/Akt and the mammalian target of rapamycin (mTOR) pathways","volume":"163","author":"Gomez","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib134","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.1118167109","article-title":"Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors","volume":"109","author":"den Boon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"46","key":"10.1016\/j.phrs.2025.107657_bib135","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.364","article-title":"Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1\/2 inactivation","volume":"5","author":"Latini","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107657_bib137","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2016.01.047","article-title":"The molecular mechanism and effect of cannabinoid-2 receptor agonist on the blood-spinal cord barrier permeability induced by ischemia-reperfusion injury","volume":"1636","author":"Yang","year":"2016","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib138","first-page":"443","article-title":"Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia-reperfusion through activating cannabinoid receptor 2","volume":"31","author":"Cai","year":"2015","journal-title":"Xi Bao Yu Fen. Zi Mian Yi Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib139","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11259-016-9655-8","article-title":"Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer- type chicks: role of glutamate NMDA and AMPA receptors","volume":"40","author":"Keyshams","year":"2016","journal-title":"Vet. Res Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/STROKEAHA.116.014793","article-title":"Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke","volume":"48","author":"Bravo-Ferrer","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2025.107657_bib141","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2018.07.020","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons","volume":"139","author":"Stumpf","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107657_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135207","article-title":"Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Abeta-induced neuronal toxicity","volume":"735","author":"Zhao","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123548","article-title":"The neuroprotective effects of the CB2 agonist GW842166x in the 6-OHDA mouse model of Parkinson's disease","volume":"10","author":"Yu","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib144","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13195-021-00920-6","article-title":"N-Methyl-D-aspartate (NMDA) and cannabinoid CB(2) receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors","volume":"13","author":"Rivas-Santisteban","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.phrs.2025.107657_bib145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2022.08.002","article-title":"N-linoleyltyrosine protects neurons against Abeta(1-40)-induced cell toxicity via autophagy involving the CB(2)\/AMPK\/mTOR\/ULK1 pathway","volume":"188","author":"Zhou","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib146","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/jn.00137.2024","article-title":"JWH133 attenuates behavior deficits and iron accumulation in 6-OHDA-induced Parkinson's disease model rats","volume":"132","author":"Liu","year":"2024","journal-title":"J. Neurophysiol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib147","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neuropharm.2004.12.008","article-title":"Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy","volume":"48","author":"Valenzano","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib148","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.joen.2011.09.015","article-title":"Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2","volume":"38","author":"Flake","year":"2012","journal-title":"J. Endod."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib149","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phrs.2012.11.002","article-title":"Cannabinoid agonists increase the interaction between beta-Arrestin 2 and ERK1\/2 and upregulate beta-Arrestin 2 and 5-HT(2A) receptors","volume":"68","author":"Franklin","year":"2013","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2025.107657_bib150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","article-title":"beta-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","volume":"135","author":"Bahi","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2025.107657_bib151","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fneur.2014.00161","article-title":"Differential expression of brain cannabinoid receptors between repeatedly stressed males and females may play a role in age and gender-related difference in traumatic brain injury: implications from animal studies","volume":"5","author":"Xing","year":"2014","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2025.107657_bib152","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuroscience.2017.03.061","article-title":"Anxious behavior induces elevated hippocampal Cb(2) receptor gene expression","volume":"352","author":"Robertson","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib153","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1113\/jphysiol.2014.286633","article-title":"Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission","volume":"593","author":"Kim","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2025.107657_bib154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2017.08.053","article-title":"Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus","volume":"363","author":"Li","year":"2017","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17796-y","article-title":"Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107657_bib156","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Fogaca","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib157","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.pharep.2018.01.010","article-title":"Effects of central RVD-hemopressin(alpha) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat","volume":"70","author":"Recinella","year":"2018","journal-title":"Pharm. Rep."},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib158","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41386-020-0696-x","article-title":"Cannabinoid CB(2) receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear","volume":"45","author":"Ivy","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2025.107657_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110284","article-title":"CB(1) and CB(2) receptors in the bed nucleus of the stria terminalis differently modulate anxiety-like behaviors in rats","volume":"110","author":"Gomes-de-Souza","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107657_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112925","article-title":"Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A\/hypocretin-1","volume":"149","author":"Ten-Blanco","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2025.107657_bib161","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1093\/cercor\/bhac220","article-title":"Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex","volume":"33","author":"Uzuneser","year":"2023","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.phrs.2025.107657_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.975020","article-title":"CB2 cannabinoid receptor expression is increased in 129S1\/SvImJ mice: behavioral consequences","volume":"13","author":"Ten-Blanco","year":"2022","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib163","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1089\/can.2023.0186","article-title":"Electrophysiological phenotypes of hippocampal synaptic and network functions in cannabinoid receptor 2 knockout mice","volume":"9","author":"Li","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.phrs.2025.107657_bib164","first-page":"291","article-title":"Methods to study the behavioral effects and expression of CB2 cannabinoid receptor and its gene transcripts in the chronic mild stress model of depression","volume":"123","author":"Onaivi","year":"2006","journal-title":"Methods Mol. Med"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000100778","article-title":"Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain","volume":"54","author":"Onaivi","year":"2006","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib166","article-title":"Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?","volume":"32","author":"Saito","year":"2010","journal-title":"Braz. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib167","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3390\/ph3082517","article-title":"Brain CB(2) receptors: implications for neuropsychiatric disorders","volume":"3","author":"Roche","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"46","key":"10.1016\/j.phrs.2025.107657_bib168","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017403","article-title":"The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: a meta-analysis","volume":"98","author":"Kong","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2025.107657_bib169","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12640-017-9708-y","article-title":"Changes in the brain endocannabinoid system in rat models of depression","volume":"31","author":"Smaga","year":"2017","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.phrs.2025.107657_bib171","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuro.2017.08.012","article-title":"Changes in the cannabinoids receptors in rats following treatment with antidepressants","volume":"63","author":"Smaga","year":"2017","journal-title":"Neurotoxicology"},{"issue":"8","key":"10.1016\/j.phrs.2025.107657_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23081836","article-title":"Cannabinoid CB2 receptor gene and environmental interaction in the development of psychiatric disorders","volume":"23","author":"Ishiguro","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2025.107657_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108717","article-title":"Ketamine-induced antidepressant like effects in mice: a possible involvement of cannabinoid system","volume":"112","author":"Khakpai","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172833","article-title":"Influence of the CB(1) and CB(2) cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice","volume":"188","author":"Poleszak","year":"2020","journal-title":"Pharm. Biochem Behav."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050792","article-title":"Antidepressant-like effect of terpineol in an inflammatory model of depression: involvement of the cannabinoid system and D2 dopamine receptor","volume":"10","author":"Vieira","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib176","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1002\/ptr.7318","article-title":"Antidepressant-like effect of rosmarinic acid during LPS-induced neuroinflammatory model: the potential role of cannabinoid receptors\/PPAR-gamma signaling pathway","volume":"35","author":"Lataliza","year":"2021","journal-title":"Phytother. Res"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043828","article-title":"Cannabinoid receptor 2 blockade prevents anti-depressive-like effect of cannabidiol acid methyl ester in female WKY rats","volume":"24","author":"Hen-Shoval","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib178","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/neu.2023.35","article-title":"Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviours","volume":"36","author":"Maes","year":"2024","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.phrs.2025.107657_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116048","article-title":"Discovery of a CB(2) and 5-HT(1A) receptor dual agonist for the treatment of depression and anxiety","volume":"265","author":"Yang","year":"2024","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.phrs.2025.107657_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155929","article-title":"Schisandra chinensis lignans regulate and cooperate with endogenous cannabinoid systems to ameliorate intestinal barrier injury associated with depression","volume":"133","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040464","article-title":"Increasing CB2 receptor activity after early life stress prevents depressive behavior in female rats","volume":"14","author":"Andersen","year":"2024","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.phrs.2025.107657_bib182","first-page":"380","article-title":"Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans","volume":"7","author":"Ishiguro","year":"2007","journal-title":"Pharm. J."},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib183","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2025.107657_bib184","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.01.030","article-title":"The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats","volume":"1444","author":"Adamczyk","year":"2012","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.phrs.2025.107657_bib185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1530-0277.2011.01686.x","article-title":"Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala","volume":"36","author":"Serrano","year":"2012","journal-title":"Alcohol Clin. Exp. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib186","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1369-1600.2011.00314.x","article-title":"Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking","volume":"17","author":"Gamaleddin","year":"2012","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029900","article-title":"Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking","volume":"7","author":"Gamaleddin","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib188","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2013.157","article-title":"Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine","volume":"38","author":"Navarrete","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib189","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00213-013-3117-6","article-title":"The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice","volume":"229","author":"Ignatowska-Jankowska","year":"2013","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.drugalcdep.2013.08.023","article-title":"Differential expression and functional role of cannabinoid genes in alcohol users","volume":"133","author":"Agudelo","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.phrs.2025.107657_bib191","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","article-title":"The cannabinoid receptor 2 agonist, beta-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice","volume":"124","author":"Al Mansouri","year":"2014","journal-title":"Pharm. Biochem Behav."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib192","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/adb.12076","article-title":"Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol","volume":"20","author":"Ortega-Alvaro","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.phrs.2025.107657_bib193","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbr.2015.03.051","article-title":"Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption","volume":"287","author":"Pradier","year":"2015","journal-title":"Behav. Brain Res"},{"issue":"12","key":"10.1016\/j.phrs.2025.107657_bib194","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/acer.12894","article-title":"Genetic versus pharmacological assessment of the role of cannabinoid type 2 receptors in alcohol reward-related behaviors","volume":"39","author":"Powers","year":"2015","journal-title":"Alcohol Clin. Exp. Res"},{"issue":"11","key":"10.1016\/j.phrs.2025.107657_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115908","article-title":"Role of cannabinoid CB2 receptor in alcohol use disorders: from animal to human studies","volume":"23","author":"Garcia-Gutierrez","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107657_bib196","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnbeh.2017.00015","article-title":"Effects of intermittent alcohol exposure on emotion and cognition: a potential role for the endogenous cannabinoid system and neuroinflammation","volume":"11","author":"Sanchez-Marin","year":"2017","journal-title":"Front Behav. Neurosci."},{"key":"10.1016\/j.phrs.2025.107657_bib197","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pbb.2016.11.005","article-title":"Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences","volume":"152","author":"Marco","year":"2017","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.phrs.2025.107657_bib198","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.alcohol.2017.01.014","article-title":"Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via endocannabinoid receptors","volume":"61","author":"Seleverstov","year":"2017","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib199","first-page":"269","article-title":"Attenuation of cocaine-induced conditioned place preference and motor activity via cannabinoid CB2 receptor agonism and CB1 receptor antagonism in rats","volume":"20","author":"Delis","year":"2017","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"20","key":"10.1016\/j.phrs.2025.107657_bib200","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3061","article-title":"Behavioral evaluation of seeking and preference of alcohol in mice subjected to stress","volume":"8","author":"Canseco-Alba","year":"2018","journal-title":"Bio Protoc."},{"key":"10.1016\/j.phrs.2025.107657_bib201","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2018.11.043","article-title":"Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons","volume":"360","author":"Canseco-Alba","year":"2019","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.phrs.2025.107657_bib202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bcp.2018.07.041","article-title":"Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol","volume":"157","author":"Navarrete","year":"2018","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pbb.2019.06.007","article-title":"Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system","volume":"183","author":"Martin-Sanchez","year":"2019","journal-title":"Pharm. Biochem Behav."},{"issue":"9","key":"10.1016\/j.phrs.2025.107657_bib204","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/bph.14969","article-title":"beta-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents","volume":"177","author":"He","year":"2020","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib205","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41386-020-00885-4","article-title":"Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARalpha and PPARgamma: repurposing a FDA-approved food additive for cocaine use disorder","volume":"46","author":"Galaj","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2025.107657_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722476","article-title":"beta-caryophyllene, an FDA-approved food additive, inhibits methamphetamine-taking and methamphetamine-seeking behaviors possibly via CB2 and Non-CB2 receptor mechanisms","volume":"12","author":"He","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib207","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13249","article-title":"beta-caryophyllene, a cannabinoid receptor 2 agonist, decreases the motivational salience and conditioning place preference for palatable food in female mice","volume":"28","author":"Dos Santos Barbosa","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.phrs.2025.107657_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106034","article-title":"Role of CB2 cannabinoid receptor in the development of food addiction in male mice","volume":"179","author":"Garcia-Blanco","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib209","first-page":"26","article-title":"CB2 agonist mitigates cocaine-induced reinstatement of place preference and modulates the inflammatory response in mice","volume":"35","author":"Abboussi","year":"2024","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.phrs.2025.107657_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108241","article-title":"Xie2-64, a novel CB(2) receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents","volume":"176","author":"Jordan","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib211","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00213-019-05370-5","article-title":"The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice","volume":"237","author":"Lopes","year":"2020","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/pr.110.003491","article-title":"The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications","volume":"63","author":"Miller","year":"2011","journal-title":"Pharm. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2025.107657_bib213","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.54.3.459","article-title":"Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity","volume":"54","author":"Shen","year":"1998","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107657_bib214","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 Cannabinoid receptors as a therapeutic target-what does the future hold","volume":"86","author":"Dhopeshwarkar","year":"2014","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2025.107657_bib215","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/oby.24019","article-title":"Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile","volume":"32","author":"Cohen","year":"2024","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.phrs.2025.107657_bib216","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111556","article-title":"CB2 receptor involvement in the treatment of substance use disorders","volume":"11","author":"Navarrete","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib217","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1021\/acscentsci.3c01461","article-title":"Flipping the GPCR switch: structure-based development of selective cannabinoid receptor 2 inverse agonists","volume":"10","author":"Kosar","year":"2024","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib218","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/07391102.2019.1567384","article-title":"Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist","volume":"38","author":"Pandey","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib219","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/acs.jmedchem.8b00368","article-title":"Identification of the first synthetic allosteric modulator of the CB(2) receptors and evidence of its efficacy for neuropathic pain relief","volume":"62","author":"Gado","year":"2019","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2025.107657_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108448","article-title":"Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice","volume":"188","author":"Shapiro","year":"2021","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2025.107657_bib221","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.bjp.0707480","article-title":"Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists","volume":"153","author":"Lunn","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2025.107657_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107330","article-title":"Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor","volume":"300","author":"Tomasevic","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2025.107657_bib223","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14539","article-title":"Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)","volume":"35","author":"Chang","year":"2023","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.phrs.2025.107657_bib224","article-title":"Safety, pharmacokinetics, and efficacy of olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, in a phase 2a study of patients with chronic abdominal pain associated With Crohn's disease","volume":"3","author":"Yacyshyn","year":"2021","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.phrs.2025.107657_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107775","article-title":"Cannabinoid receptor 2 (CB2) modulators: a patent review (2016-2024)","volume":"153","author":"Naikoo","year":"2024","journal-title":"Bioorg. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:26:31Z","timestamp":1745569591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":225,"alternative-id":["S1043661825000829"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107657","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107657"}}